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Abstract
Purpose of review—Recent epidemiologic investigations suggest that occupational and 
environmental exposures contribute to the overall burden of idiopathic pulmonary fibrosis (IPF). 
This article explores the epidemiologic and clinical challenges to establishing exposure 
associations, the current literature regarding exposure disease relationships and the diagnostic 
work-up of IPF and asbestosis patients.
Recent findings—IPF patients demonstrate a histopathologic pattern of usual interstitial 
pneumonia. In the absence of a known cause or association, a usual interstitial pneumonia pattern 
leads to an IPF diagnosis, which is a progressive and often terminal fibrotic lung disease. It has 
long been recognized that asbestos exposure can cause pathologic and radiographic changes 
indistinguishable from IPF. Several epidemiologic studies, primarily case control in design, have 
found that a number of other exposures that can increase risk of developing IPF include cigarette 
smoke, wood dust, metal dust, sand/silica and agricultural exposures. Lung mineralogic analyses 
have provided additional support to causal associations. Genetic variation may explain differences 
in disease susceptibility among the population.
Summary—An accumulating body of literature suggests that occupational and environmental 
exposure can contribute to the development of IPF. The impact of exposure on the pathogenesis 
and clinical course of disease requires further study.
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INTRODUCTION
The idiopathic interstitial pneumonias encompass a diverse range of clinico-radio-pathologic 
disorders. Among the idiopathic interstitial pneumonias, idiopathic pulmonary fibrosis (IPF) 
is the most common. Usual interstitial pneumonia (UIP) represents the pathologic pattern 
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seen in IPF. Despite the presumption that no cause exists, several epidemiologic studies 
implicate exposure risk factors including tobacco smoke, wood and metal dust [1–9]. Given 
that epithelial injury is likely the initial event, the presence of an inciting exposure is 
biologically plausible. Genetic susceptibility may explain why exposure elicits disease in 
only some individuals. Although a UIP pattern is usually presumed to be ‘idiopathic’, the 
current literature supports a relationship between exposures, in addition to asbestos and UIP.
Other interstitial lung diseases such as nonspecific interstitial pneumonia and chronic 
hypersensitivity pneumonitis have been associated with a number of exposures, particularly 
organic antigens emanating from a variety of sources such as dairy and grain products, 
animal dander and protein and water reservoir vaporizers. These interstitial lung diseases 
have distinct radiologic and pathologic patterns and are not addressed in this review.
USUAL INTERSTITIAL PNEUMONIA: OCCUPATIONAL AND OTHER RISK 
FACTORS
Idiopathic pulmonary fibrosis represents the most commonly identified idiopathic interstitial 
pneumonia. UIP is the pathologic pattern associated with IPF, but may be seen in 
association with connective tissue diseases, medication toxicity and occupational exposures 
such as asbestos [10].
Epidemiology studies of IPF have been hindered by several challenges, including changes in 
disease classification and diagnostic approaches, and also the many challenges involved in 
assessing chronic usually mixed exposures over many years. Recent epidemiologic studies 
suggest an increasing prevalence of IPF. Raghu et al. [11], using an administrative dataset, 
reported a prevalence of interstitial lung disease (ILD) of 14.0 and 42.7 per 100 000 
depending on case definition. Increasing age, male sex and smoking increase the risk for 
ILD [11]. Gastroesophageal reflux disease, a type of ‘exposure’, also increases risk. 
Researchers are currently investigating whether aggressive reflux treatment, such as with 
Nissen fundoplication, alters disease course [12,13▪].
Several studies, mostly case control in design, have demonstrated associations between 
exposure and IPF [1–4,6–8,14▪▪]. Smoking has consistently been reported as a risk factor for 
IPF with a population-attributable risk estimated at 49% [9]. For example, in the United 
States, Baumgartner et al. [2] reported an odds ratio (OR) of 1.6 for ever smokers In a recent 
Swedish study of 181 patients enrolled in a long-term oxygen registry, Ekstrom et al. [15▪▪] 
reported significant interactions between smoking, male sex and occupational exposure, 
with an OR of 3.0 [95% confidence interval (CI) 1.3–6.5] for exposed IPF patients 
compared to nonexposed women. Although inconsistently reported in the past, a dose 
response to smoking was observed [15▪▪].
Several studies have consistently shown an increased IPF risk in association with specific 
exposures including metal dust, wood dust, stone/silica and farming.
Hubbard et al. [6] analyzed data derived from mailed questionnaires and telephone 
interviews in 218 patients and 569 match-based controls in the United Kingdom. Dose 
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response increases in IPF risk were found in association with metal dust (OR 1.69, 95% CI 
1.07–2.65), wood dust (OR 1.71, 95% CI 1.01–2.92), as well as associations with stone/sand 
(OR 1.76, 95% CI 1.01–3.07) and textile dust (OR 1.80, 95% CI 1.10–2.96) [6].
In Japan, Iwai et al. [7] used data from autopsy records in 1311 IPF patients to report an OR 
of 3.01 (95% CI 1.29–7.43) with agricultural exposures and 1.34 (95% CI 1.14–1.59) among 
metal workers.
In 2000, Baumgartner et al. [1] recruited 248 IPF patients through a random digit dialing 
method and demonstrated associations with livestock (OR 2.70, 95% CI 1.30–5.50), sand/
stone/silica (OR 3.90, 95% CI 1.20–12.70) and metal dust exposures (OR 2.00, 95% CI 
1.00–4.00). A dose–response relationship was seen in association with metal dust [1].
Hubbard et al. [5] investigated IPF risk in 20 526 workers employed at a major engineering 
company in the United Kingdom using pension-fund mortality data and historic 
occupational records to assess exposures. An increased proportional mortality ratio of 1.39 
was found in this cohort compared to national data, with a significant dose response seen in 
workers exposed to metals (OR per 10 years of metal exposure of 1.71, 95% CI 1.09–2.68) 
[5].
Using extensive occupational data from 181 pulmonary fibrosis patients including 140 with 
IPF enrolled in a Swedish Oxygen Registry, Gustafson et al. [4] demonstrated an increased 
risk of IPF in men with exposure to birch dust (OR 2.7, 95% CI 1.30–5.65) and hardwood 
dust (OR 2.7, 95% CI 1.14–6.52).
In a recent Egyptian hospital-based case control study, exposure data from 201 confirmed 
IPF cases and 205 controls were compared. Carpentry and woodworking (OR 2.56, 95% CI 
1.02–7.01), and chemical and petrochemical occupational exposures (OR 6.47, 95% 1.66–
25.12) were associated with increased IPF risk [16].
The Korean Interstitial Lung Disease Research Group recently conducted a national cross-
sectional survey of 1311 IPF patients, stratified into five occupational groups. Dust-exposed 
workers showed earlier-onset ILD, and dust exposure occupation was associated with 
increased mortality (hazard ratio 1.813, 95% CI 1.049–3.133) [14▪▪].
Several novel exposures or novel uses of old exposures have recently been implicated in the 
development of ILD. Raghu et al. [17] reported a case of a 64-year-old male patient who for 
many years had ground, machined and drilled Corian, a solid surface material composed of 
acrylic polymer and aluminum triyhydrate. Pathology revealed birefringent crystals on 
polarizable microscopy and autopsy revealed evidence of aluminum trihydroxide. Past 
studies have suggested a link between aluminum and interstitial lung disease [17].
Mineralogic analysis of lung tissue has been used to evaluate exposure in UIP patients. An 
excess of silica, and metals, including iron and nickel, has been reported in several studies 
[18–20]. Using scanning electron microscopy and energy dispersive X-ray analysis, Monso 
et al. [20] reported elevated surface silica to sulfur ratios among six IPF patients compared 
to controls. Postulating that exposures may be concentrated in lymph nodes, a recent 
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Japanese study of 23 IPF cases versus 23 controls demonstrated an excess of silicon and 
aluminum in the pulmonary hilar lymph nodes [21].
Although familial IPF is rare, investigators have described several genetic associations in 
patients with sporadic IPF, including genetic variations in surfactant protein C and A, human 
telomerase reverse transcriptase and more recently MUC5B [22]. The causative contribution 
of respiratory exposure to IPF is potentially supported by the identification of a MUC5B 
genetic variant. MUC5B encodes mucin glycoproteins and it is postulated that defects in 
mucin glycoprotein may make airways more susceptible to injury [22].
ASBESTOSIS
Asbestos refers to a group of naturally occurring fibers composed of hydrated magnesium 
silicates that are commercially valuable due to its strength, flexibility and resistance to 
electrical, thermal and chemical degradation. Two categories of asbestos exist: serpentine – 
long, curly fibers; and amphibole – long straight rod-like structures. Chrysotile is the only 
significant commercially used serpentine fiber. Amphibole fibers include crocidolite, 
amosite, anthophylite, actinolite and tremolite. Chrysotile fiber use is more common, 
whereas amphibole fibers are considered more toxic.
In addition to its association with lung cancer, mesothelioma, small airways disease and 
pleural disease, asbestos exposure can lead to asbestosis, a form of interstitial lung disease 
often indistinguishable from IPF [23,24].
The WHO estimates that 1.3 million and 125 million workers in the United States and 
worldwide, respectively, have experienced asbestos exposure during mining or milling or 
during its use in several industries such as building and construction, shipbuilding and the 
automotive industry [25▪]. An estimated 13 885 individuals died of asbestosis between 1994 
and 2010 with a potential loss of 180 000 years of life lost [26▪]. In the United States, the 
number of deaths attributed to asbestos reached 1493 in 2000 and declined to 1470 by 2004 
[25▪]. The median age at death is generally 79 years [27▪]. Asbestosis increased the risk for 
lung cancer as demonstrated from a study of 339 North American Insulator workers who 
died from lung cancer. The rate ratio for lung cancer for exposed nonsmokers versus 
smokers was 7.40 (95% CI 4.0–13.7) and 36.8 (95% CI 30.1–45.0) [28▪]. The asbestos 
exposure that emanated from the collapse of the World Trade Centers was a reminder of the 
asbestos that still remains in older buildings and that the long-terms effects of such exposure 
should be monitored over time [29].
Asbestos consumption remains substantial in Eastern European, South American and Asian 
countries [25▪]. China, for example, is the leading consumer of asbestos and the second 
largest producer of worldwide asbestosis. The number of asbestosis cases among Chinese 
miners [30] and factory workers exceed the number of cases found in developing countries. 
For example, in a cohort study of Chinese asbestos factory workers, 39 of 259 deaths 
observed in 586 male asbestos workers were due to asbestosis [31▪].
Nonoccupational environmental exposure to asbestos is also a concern. Environmental 
exposure can occur from exposure to the soiled clothes of asbestos workers. Mining, road 
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construction, agricultural and natural weathering and development may lead to 
nonoccupational exposures from naturally occurring asbestos, minerals found as natural 
components of soils and rock. Asbestosrelated diseases, predominantly pleural plaques and 
mesothelioma, have been reported in association with environmental exposures in areas such 
as China, Corsica, Turkey, Greece, Cyprus and California [32▪]. Asbestos-containing soil 
has been routinely used in the plastering, whitewashing and roof insulation of houses in 
countries such as Greece [33]. The use of serpentinite in New Caledonia for road surfacing 
has been reported as a risk factor for mesothelioma [34]. Erionite, technically not asbestos 
but similar to a long thin amphibole fiber, found in white stucco and soil, in Turkey, has 
been associated with mesothelioma [35]. Proximity to industrial sources with some 
modification of exposure by wind direction has been reported as, for example, in Libby, 
Montana, the world’s largest vermiculite mine and processing operation [36]. Residents of 
Libby endured exposure to the vermiculite ore contaminated with amphibole asbestos 
resulting from past industrial production. While pleural disease has been reported most 
commonly, parenchymal abnormalities have also been reported [37].
Inhaled asbestos fibers deposited at the level of the respiratory bronchiole and alveolar duct 
bifurcations exert a direct deleterious effect on the lung. Lung deposition stimulates the 
release of various mediators including cytokines, growth factors, proteases and reactive 
oxidative species. By impairing mucociliary clearance mechanisms, smoking may increase 
risk for asbestosis. Gene environment interactions might further influence the development 
of the disease [38▪]. Franko et al. [38▪] reported several gene–gene environment interactions 
on the risk of asbestosis including a strong interaction between glutathione S-transferase 
GSTM1-null polymorphism and smoking and iNOS (CCTTT)n polymorphism and smoking, 
and between iNOS (CCTTT)n and cumulative asbestos exposure. A glutathione S-
transferase GSTT1 deletion may protect against asbestosis [39].
Work-up of patients with possible asbestosis includes radiographic imaging and requires 
histopathologic confirmation only when the exposure history is indeterminate. At early 
stages, chest computed tomography (CT) scans may be more sensitive while at more 
advanced stages the CT scan is indistinguishable from IPF. Pleural plaques indicate prior 
exposure [40]. Physiologic testing correlates with radiographic abnormalities, and diffusion 
capacity is more sensitive at detecting progressive disease [41]. The diagnostic assessment is 
further reviewed below.
DIAGNOSTIC WORK-UP
The diagnostic work-up of any patient with ILD includes a comprehensive history, 
radiographic assessment, preferably with high-resolution chest CT scan, and pulmonary 
function testing. Biopsies are not routinely required.
History
Identifying culprit exposures require a high index of clinical suspicion and a comprehensive 
history. Given the long latency between exposure and disease, clinicians should inquire 
about the present and past jobs and employers, as well as the presence of disease among co-
workers. Providers should obtain more detailed information such as specific work tasks and 
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workplace materials. For example, workers in the machining trades such as machinists and 
tool and die operators, and workers in fabricating trades such as welders and blacksmiths 
may be exposed to metal dust. Clinicians should ask about visible dust exposure, the 
presence of appropriate engineering controls such as local exhaust ventilation and finally the 
use of personal protective equipment such as respirators.
Asbestos exposure traditionally has occurred during mining of fibers or industrial 
applications such as in shipbuilding or insulation work. Nonoccupational asbestos-related 
disease has been reported, such as among individuals with regular exposure to the clothes of 
asbestos workers and in individuals with environmental exposures to industrial sources as in 
Libby, Montana [36].
Radiology
Chest radiographs are routinely performed in the diagnostic work-up of dyspneic patients 
and as part of workplace respiratory surveillance programs such as asbestos surveillance 
programs mandated by the Occupational Safety and Health Administration. Whereas chest 
radiographs are often insensitive in detecting the subtle lower lobe reticular abnormalities in 
early disease, traction bronchiectasis and honeycombing may be evident in the advanced 
stages.
International Labor Office (ILO) classification of chest radiographs for persons with 
pneumoconiosis standardizes and grades the presence of radiographic abnormalities 
including the size, shape and distribution, profusion of small opacities, and presence and 
type of pleural abnormalities. The use of standard digital images to classify chest 
radiographs has recently been validated [42,43], facilitating on-going respiratory 
surveillance of occupationally exposed workers using modern methodology [44]. In addition 
to the interstitial changes described in UIP, asbestosis patients may also show evidence of 
pleural plaques.
High-resolution computed tomography (HRCT) provides a more detailed delineation of 
parenchymal abnormalities with 1-mm slice cuts. Given that subtle abnormalities at the 
bases may actually represent dependent atelectasis, prone imaging can be quite useful in 
patients with early disease. As the presence of significant air trapping or mosaic attenuation 
excludes the diagnosis of usual interstitial pneumonia, inspiratory and expiratory imaging 
should be part of the standard high-resolution chest CT scan protocol.
Recent data from chest CT scan studies in lung cancer screening have demonstrated that 
with respect to asbestos patients, chest CT scans detect three to five times more cases of 
minor disease. Individuals with asbestosis were generally older and had a longer exposure 
latency period [45▪].
Whereas asbestosis CT scans may appear indistinguishable from patients IPF, the presence 
of certain radiographic clues may be particularly helpful in patients who have indeterminate 
or unknown asbestos exposure. Such clues include the presence of pleural disease such as 
pleural plaques and pleural thickening. Bilateral pleural plaques are pathognomonic for 
asbestos exposure (Fig. 1). Rounded atelectasis, frequently mistaken for malignancy, is an 
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area of focal lung collapse surrounded by invaginated pleura and is often seen in asbestosis 
patients. Given the increased risk for lung cancer and mesothelioma, clinicians should 
scrutinize CT scans for malignancy as well. The severity of radiographic appearance 
correlates with mortality [46▪,47].
In advanced stages, HRCT is sufficient to document UIP. IPF guidelines delineate three 
radiographic patterns: a UIP pattern, a possible UIP pattern and a pattern inconsistent with 
UIP. A UIP pattern is characterized by subpleural basilar predominance, reticular 
abnormalities and honey-combing with or without traction bronchiectasis. A possible UIP 
pattern lacks honeycombing, whereas an inconsistent pattern includes features such as upper 
lobe predominance, ground glass opacities, nodular opacities, bronchovascular 
predominance, cysts and/or air trapping or mosaic attenuation in three or more lobes [10]. 
Of note, the presence of upper lobe predominance and air trapping/mosaic attenuation in a 
patient with fibrotic lung disease suggests chronic hypersensitivity pneumonitis, a disease 
described in association with a number of organic antigens.
Pulmonary function testing and respiratory surveillance programs
Fibrotic lung disease patients demonstrate a restrictive ventilatory defect accompanied by a 
reduced diffusion capacity. A reduced forced vital capacity in the absence of obstruction 
while suggestive of restrictive disease is not diagnostic. Total lung capacity, generally 
obtained by helium dilution or body plethysmography, is required to officially establish a 
diagnosis. The presence of a mixed obstructive and restrictive pattern may be due to 
concomitant emphysema frequently seen in smokers. Given that smoking itself is a risk 
factor for UIP, the presence of obstruction is certainly seen in clinically practice and the 
entity of combined fibrosis with emphysema has been described. Mild airflow obstruction in 
asbestosis workers may alternatively reflect the presence of small airways disease.
Reductions in diffusion capacity are also seen in patients with fibrotic disease. Six-minute 
walk tests may unmask oxygen desaturation in patients who maintain a normal oxygen 
saturation at rest. Studies demonstrate that longitudinal changes in lung function as well as 
the presence of oxygen desaturation portend poorer outcomes. Reductions in diffusion 
capacity and vital capacity correlate with severity of radiographic abnormalities. Among 
asbestos workers, recent studies have also demonstrated accelerated declines in lung 
function during an individual’s working life with smoking and exposure having synergistic 
effects [10,48].
Histopathology
Histopathologic confirmation is not uniformly required in clinical care for UIP or asbestosis 
patients.
In the absence of a definitive UIP CT scan, video-assisted thorascopically obtained surgical 
specimens should be considered. Current guidelines delineate four categories of usual 
interstitial pneumonia – UIP pattern, probable UIP pattern, possible UIP pattern and a not 
UIP pattern. A UIP pattern includes the presence of marked fibrosis, architectural distortion 
in a subpleural paraseptal fibrosis, presence of patchy involvement, fibroblastic foci and the 
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absence of atypical features (Fig. 2). A final diagnosis requires an overall clinico-radio-
pathologic assessment [10] (Fig. 2).
For the asbestosis patient, a strong exposure history in the presence of fibrotic lung disease 
on HRCT is sufficient for diagnosis. In a patient with an intermediate exposure history or a 
history of bystander exposure, the presence of pleural plaques is sufficient for diagnosis. 
Whereas histopathologic findings in advanced asbestosis may resemble UIP, early asbestosis 
features may reveal only disease centered around the bronchioles. In contrast to UIP, 
fibroblastic foci are less prominent, whereas mild fibrosis of the visceral pleura is more 
commonly seen [49].
Lung mineralogic analyses documenting exposure can impact individual patient care and 
from an epidemiologic perspective provide further evidence of exposure disease 
relationships [18–20,50] From a direct clinical care perspective, demonstration of asbestos 
bodies in lung tissue can be quite helpful (Fig. 3). Histopathologic confirmation of asbestos 
exposure is not uniformly required. For example, an individual with a strong history of 
exposure in the presence of fibrotic lung disease on HRCT does not require histopathologic 
confirmation. An individual with an indeterminate history of exposure with fibrotic lung 
disease who also demonstrates pleural plaques, considered pathognomonic for asbestos 
exposure, similarly does not require histopathologic confirmation. In comparison to 
amphibole fibers, chrysotile fibers are more rapidly cleared.
For patients with indeterminate asbestos exposure histories, histopathologic confirmation 
may be useful. With light microscopy, iron stains should be requested to detect asbestos 
bodies. Asbestos bodies are golden brown, beaded dumbbell-shaped structures with a thin 
translucent core. The thin translucent asbestos core is surrounded by an iron protein 
mucopolysaccharide coating. A similar coating surrounds other particles such a glass, talc, 
iron or carbon. Accurate identification of asbestos requires scanning electron microscopy 
with energy dispersive X-ray analysis. Light microscopy generally underestimates the 
asbestos burden by 10–10 000-fold. Generally, an average concentration of asbestos bodies 
of at least 2/cm2 of lung is recommended to make a diagnosis of asbestosis (Fig. 3). The 
presence of 1 asbestos body/ml of bronchoalveolar lavage fluid is deemed to represent 
significant asbestos exposure [49].
For UIP patients without a history of asbestos exposure, lung mineralogic analyses can 
identify possible contributing exposures, such as silicates or metals. From a research 
perspective, lung mineralogic analyses provide further insight into exposure disease 
relationships. An excess of silica and metals, including iron and nickel, has been reported 
[18–20]. Postulating that exposures may be concentrated in lymph nodes, a recent Japanese 
study demonstrated an excess of elemental particles such as silica and aluminum in IPF 
patients [21].
Prognosis and treatment
For IPF patients, although clinicians generally cite a median survival of 3 years, recent 
evidence suggests that outcomes are heterogeneous. Patients may decline slowly, rapidly or 
experience precipitous decline during an acute exacerbation [10,51].
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For years, lung transplant with a median survival of 4.5 years remained the only viable 
treatment option for end-stage IPF. Since the United Network for Organ Sharing issued the 
lung allocation scoring system in 2005, the proportion of IPF patients on transplant lists has 
grown and also accounted for the highest percentage of waiting list deaths [52]. Although no 
strict age cut-off exists, older patients with multiple comorbidities are frequently ineligible.
After years of failed clinical trials, two drugs have emerged as having a modest effect on 
altering disease course – pirfenidone and nintedanib. Pirfenidone is a small-molecule drug 
whose antifibrotic effects are likely mediated by the transforming growth factor beta 
pathway [53▪]. Nintedanib is a triple kinase inhibitor with antifibrotic effects [54▪]. Studies 
have demonstrated a modest effect on disease progression, particularly on forced vital 
capacity. A pooled analysis of pirfenidone studies demonstrated improved survival. 
Immunomodulatory therapy such as with prednisone and azathioprine causes increased harm 
and should be avoided unless patients are experiencing an acute exacerbation [55].
In a patient with UIP, occupational or environmental exposures that may be contributing 
should be identified by careful history and on-going exposures eliminated or reduced to the 
extent possible, including cigarette smoking and workplace exposures such as metal or wood 
dusts, although exposure intervention studies are limited. On the basis of limited evidence, it 
is believed that asbestosis progresses more slowly than usual interstitial pneumonia [49]. 
Lung transplantation may be an option for patients with progressive disease. The efficacy of 
newly approved IPF drugs nintedanib and pirfenidone in asbestosis patients is unknown. 
Acute exacerbations have also been reported in asbestosis patients [56]. As demonstrated in 
a North American cohort of insulators, asbestosis in addition to asbestos and synergistically 
with smoking increased lung cancer mortality with rate ratio of 7.40 (95% CI 4.0–13.7) 
among nonsmokers and 36.8 (95% CI 30.1–45.0) among smokers [28▪].
CONCLUSION
While asbestos has often been cited as an example of an exposure that causes disease 
indistinguishable from IPF, an accumulating body of literature suggests that a number of 
alternative exposures such as cigarette smoking, metal and wood dust and agricultural 
exposures may also contribute to the development of IPF. The impact of such exposures on 
the pathogenesis of disease, outcomes and treatment requires further study.
Acknowledgements
We would like to thank Robert Homer, MD, PhD, and Jonathan Killam, MD, for the radiographic and pathologic 
images.
Financial support and sponsorship
None.
M.G. has received funding from the National Institutes of Health and has served as an advisory board member and 
consultant for InterMune. She has also received honoraria for PILOT CME program. She has received funding for 
unrelated research from NIH.
She has received funding for unrelated research from the CDC-NIOSH.
Gulati and Redlich Page 9













REFERENCES AND RECOMMENDED READING
Papers of particular interest, published within the annual period of review, have been 
highlighted as:
▪ of special interest
▪▪ of outstanding interest
1. Baumgartner KB, Samet JM, Coultas DB, et al. Occupational and environmental risk factors for 
idiopathic pulmonary fibrosis: a multicenter case-control study. Collaborating Centers. Am J 
Epidemiol. 2000; 152:307–315. [PubMed: 10968375] 
2. Baumgartner KB, Samet JM, Stidley CA, et al. Cigarette smoking: a risk factor for idiopathic 
pulmonary fibrosis. Am J Respir Crit Care Med. 1997; 155:242–248. [PubMed: 9001319] 
3. Glazer CS, Newman LS. Occupational interstitial lung disease. Clin Chest Med. 2004; 25:467–478. 
vi. [PubMed: 15331187] 
4. Gustafson T, Dahlman-Hoglund A, Nilsson K, et al. Occupational exposure and severe pulmonary 
fibrosis. Respir Med. 2007; 101:2207–2212. [PubMed: 17628464] 
5. Hubbard R, Cooper M, Antoniak M, et al. Risk of cryptogenic fibrosing alveolitis in metal workers. 
Lancet. 2000; 355:466–467. [PubMed: 10841131] 
6. Hubbard R, Lewis S, Richards K, et al. Occupational exposure to metal or wood dust and aetiology 
of cryptogenic fibrosing alveolitis. Lancet. 1996; 347:284–289. [PubMed: 8569361] 
7. Iwai K, Mori T, Yamada N, et al. Idiopathic pulmonary fibrosis. Epidemiologic approaches to 
occupational exposure. Am J Respir Crit Care Med. 1994; 150:670–675. [PubMed: 8087336] 
8. Scott J, Johnston I, Britton J. What causes cryptogenic fibrosing alveolitis? A case-control study of 
environmental exposure to dust. Br Med J. 1990; 301:1015–1017. [PubMed: 2249047] 
9. Taskar VS, Coultas DB. Is idiopathic pulmonary fibrosis an environmental disease? Proc Am 
Thorac Soc. 2006; 3:293–298. [PubMed: 16738192] 
10. Raghu G, Collard HR, Egan JJ, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic 
pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit 
Care Med. 2011; 183:788–824. [PubMed: 21471066] 
11. Raghu G, Weycker D, Edelsberg J, et al. Incidence and prevalence of idiopathic pulmonary 
fibrosis. Am J Respir Crit Care Med. 2006; 174:810–816. [PubMed: 16809633] 
12. Lee JS. The role of gastroesophageal reflux and microaspiration in idiopathic pulmonary fibrosis. 
Clin Pulmon Med. 2014; 21:81–85.
13. Lee JS, Ryu JH, Elicker BM, et al. Gastroesophageal reflux therapy is associated with longer 
survival in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2011; 
184:1390–1394. [PubMed: 21700909] The use of gastroesophageal reflux therapy independently 
predicted longer survival time and a lower radiologic fibrosis score.
14. Lee SH, Kim DS, Kim YW, et al. Association between occupational dust exposure and prognosis 
of idiopathic pulmonary fibrosis: a Korean national survey. Chest. 2014 [Epub ahead of print]. The 
Korean Interstitial Lung Disease Research conducted a nation survey of 1311 IPF patients. The 
study found that dust-exposed workers had an earlier onset of disease and longer duration of 
symptoms at diagnosis. Dust-exposed occupations in addition to aging and baseline forced vital 
capacity were associated with mortality.
15. Ekstrom M, Gustafson T, Boman K, et al. Effects of smoking, gender and occupational exposure 
on the risk of severe pulmonary fibrosis: a population-based case-control study. Br Med J Open. 
2014; 4:e004018. In a case control study of 171 patients from a Swedish long-term oxygen 
registry, a dose-dependent relationship between smoking and severe pulmonary fibrosis was 
found. Occupational exposures increased the risk of pulmonary fibrosis in male smokers.
16. Awadalla NJ, Hegazy A, Elmetwally RA, Wahby I. Occupational and environmental risk factors 
for idiopathic pulmonary fibrosis in Egypt: a multicenter case-control study. Int J Occup Environ 
Med. 2012; 3:107–116. [PubMed: 23022860] 
Gulati and Redlich Page 10













17. Raghu G, Collins BF, Xia D, et al. Pulmonary fibrosis associated with aluminum trihydrate 
(Corian) dust. N Engl J Med. 2014; 370:2154–2156. [PubMed: 24869740] 
18. Berry JP, Henoc P, Galle P, Pariente R. Pulmonary mineral dust. A study of ninety patients by 
electron microscopy, electron microanalysis, and electron microdiffraction. Am J Pathol. 1976; 
83:427–456. [PubMed: 937507] 
19. Pariente R, Berry JP, Galle P, et al. A study of pulmonary dust deposits using the electron 
microscope in conjunction with the electron sound analyser. Thorax. 1972; 27:80–82. [PubMed: 
5017571] 
20. Monso E, Tura JM, Marsal M, et al. Mineralogical microanalysis of idiopathic pulmonary fibrosis. 
Arch Environ Health. 1990; 45:185–188. [PubMed: 2167043] 
21. Kitamura H, Ichinose S, Hosoya T, et al. Inhalation of inorganic particles as a risk factor for 
idiopathic pulmonary fibrosis–elemental microanalysis of pulmonary lymph nodes obtained at 
autopsy cases. Pathol Res Pract. 2007; 203:575–585. [PubMed: 17590529] 
22. Seibold MA, Wise AL, Speer MC, et al. A common MUC5B promoter polymorphism and 
pulmonary fibrosis. N Engl J Med. 2011; 364:1503–1512. [PubMed: 21506741] 
23. Diagnosis and initial management of nonmalignant diseases related to asbestos. Am J Respir Crit 
Care Med. 2004; 170:691–715. [PubMed: 15355871] 
24. McLemore TL, Greenberg SD, Wilson RK, et al. Update on asbestos-associated pulmonary 
disease. Texas Med. 1981; 77:38–46.
25. Stayner L, Welch LS, Lemen R. The worldwide pandemic of asbestos-related diseases. Ann Rev 
Public Health. 2013; 34:205–216. [PubMed: 23297667] A comprehensive review of the current 
incidence, prevalence and mortality of asbestos-related disease worldwide, including developing 
countries where asbestos usage remains high.
26. Diandini R, Takahashi K, Park EK, et al. Potential years of life lost (PYLL) caused by asbestos-
related diseases in the world. Am J Ind Med. 2013; 56:993–1000. [PubMed: 23907860] On the 
basis of data reported to the WHO, the burden of asbestos-related diseases remains substantial 
with 128 015 and 13 885 individuals, respectively, dying of mesothelioma and asbestosis.
27. Bang KM, Mazurek JM, Wood JM, Hendricks SA. Diseases attributable to asbestos exposure: 
years of potential life lost, United States, 1999–2010. Am J Ind Med. 2014; 57:38–48. [PubMed: 
24108494] On the basis of mortality data from 1999 to 2010 National Center for Health Statistics, 
the years of potential life lost remained stable with a total of 427 005 and 370 098 years of 
potential life lost, respectively, for asbestosis and mesothelioma.
28. Markowitz SB, Levin SM, Miller A, Morabia A. Asbestos, asbestosis, smoking, and lung cancer. 
New findings from the North American insulator cohort. Am J Respir Crit Care Med. 2013; 
188:90–96. [PubMed: 23590275] Lung cancer mortality between 1981 and 2008 obtained from the 
National Death Index demonstrated that asbestos and asbestosis as well as asbestosis 
synergistically with smoking increases the risk of lung cancer.
29. Lorber M, Gibb H, Grant L, et al. Assessment of inhalation exposures and potential health risks to 
the general population that resulted from the collapse of the World Trade Center towers. Risk 
Anal. 2007; 27:1203–1221. [PubMed: 18076491] 
30. Wang X, Lin S, Yano E, et al. Mortality in a Chinese chrysotile miner cohort. Int Arch Occup 
Environ Health. 2012; 85:405–412. [PubMed: 21796539] 
31. Wang X, Courtice MN, Lin S. Mortality in chrysotile asbestos workers in China. Curr Opin 
Pulmon Med. 2013; 19:169–173. This article reviews the recent literature regarding asbestos 
related nonmalignant respiratory diseases and cancer mortality in China, the world’s leading 
producer and consumer of chrysotile asbestos.
32. Bayram M, Bakan ND. Environmental exposure to asbestos: from geology to mesothelioma. Curr 
Opin Pulmon Med. 2014; 20:301–307. Nonoccupational environmental exposures to asbestos have 
been reported. Road construction, agricultural and natural weathering and development may lead 
to nonoccupational exposures from naturally occurring asbestos, minerals found as natural 
components of soils and rock. Asbestos-related diseases have been reported in association with 
environmental exposures in areas such as China, Corsica, Turkey, Greece, Cyprus and California.
Gulati and Redlich Page 11













33. Constantopoulos SH, Malamou-Mitsi VD, Goudevenos JA, et al. High incidence of malignant 
pleural mesothelioma in neighbouring villages of North-western Greece. Respiration. 1987; 
51:266–271. [PubMed: 3659577] 
34. Baumann F, Maurizot P, Mangeas M, et al. Pleural mesothelioma in New Caledonia: associations 
with environmental risk factors. Environ Health Perspect. 2011; 119:695–700. [PubMed: 
21193386] 
35. Baris YI, Sahin AA, Ozesmi M, et al. An outbreak of pleural mesothelioma and chronic fibrosing 
pleurisy in the village of Karain/Urgup in Anatolia. Thorax. 1978; 33:181–192. [PubMed: 663877] 
36. Antao VC, Larson TC, Horton DK. Libby vermiculite exposure and risk of developing asbestos-
related lung and pleural diseases. Curr Opin Pulmon Med. 2012; 18:161–167.
37. Larson TC, Lewin M, Gottschall EB, et al. Associations between radiographic findings and 
spirometry in a community exposed to Libby amphibole. Occup Environ Med. 2012; 69:361–366. 
[PubMed: 22383589] 
38. Franko A, Dolzan V, Arneric N, Dodic-Fikfak M. The influence of gene-gene and gene-
environment interactions on the risk of asbestosis. BioMed Res Int. 2013; 2013:405743. [PubMed: 
23984360] The relationship between gene–gene and gene–environment interactions and asbestosis 
was explored among 262 asbestosis cases.
39. Franko A, Dodic-Fikfak M, Arneric N, Dolzan V. Glutathione S-transferases GSTM1 and GSTT1 
polymorphisms and asbestosis. J Occup Environ Med. 2007; 49:667–671. [PubMed: 17563610] 
40. Roach HD, Davies GJ, Attanoos R, et al. Asbestos: when the dust settles an imaging review of 
asbestos-related disease. Radiographics. 2002; 22:S167–S184. [PubMed: 12376609] 
41. Nogueira CR, Napolis LM, Bagatin E, et al. Lung diffusing capacity relates better to short-term 
progression on HRCT abnormalities than spirometry in mild asbestosis. Am J Ind Med. 2011; 
54:185–193. [PubMed: 21298694] 
42. International Labour Office. International Labour Office guidelines for the use of the ILO 
International Classification of Radiographs of Pneumoconioses. Geneva: Switzerland International 
Labour Office; 2002. 
43. Halldin CN, Petsonk EL, Laney AS. Validation of the international labour office digitized standard 
images for recognition and classification of radiographs of pneumoconiosis. Acad Radiol. 2014; 
21:305–311. [PubMed: 24507420] 
44. Martonik JF, Nash E, Grossman E. The history of OSHA’s asbestos rule makings and some 
distinctive approaches that they introduced for regulating occupational exposure to toxic 
substances. AIHAJ. 2001; 62:208–217. [PubMed: 11331993] 
45. Carrillo MC, Alturkistany S, Roberts H, et al. Low-dose computed tomography (LDCT) in workers 
previously exposed to asbestos: detection of parenchymal lung disease. J Comput Assist Tomogr. 
2013; 37:626–630. [PubMed: 23863542] In a study of workers exposed to asbestos for over 20 
years who were screened for lung cancer and mesothelioma, 44% of individuals showed evidence 
of parenchymal disease.
46. Vehmas T, Oksa P. Chest HRCT signs predict deaths in long-term follow-up among asbestos 
exposed workers. Eur J Radiol. 2014; 83:1983–1987. [PubMed: 25106847] Several HRCT 
features predicted mortality among 633 asbestos workers including and not limited to irregular/
linear opacities and honeycombing.
47. Huuskonen O, Kivisaari L, Zitting A, et al. High-resolution computed tomography classification of 
lung fibrosis for patients with asbestos-related disease. Scand J Work Environ Health. 2001; 
27:106–112. [PubMed: 11409592] 
48. Wang XR, Yano E, Wang M, et al. Pulmonary function in long-term asbestos workers in China. J 
Occup Environ Med. 2001; 43:623–629. [PubMed: 11464393] 
49. Roggli VL, Gibbs AR, Attanoos R, et al. Pathology of asbestosis: an update of the diagnostic 
criteria: report of the Asbestosis Committee of the College of American Pathologists and 
Pulmonary Pathology Society. Arch Pathol Lab Med. 2010; 134:462–480. [PubMed: 20196674] 
50. Monso E, Tura JM, Pujadas J, et al. Lung dust content in idiopathic pulmonary fibrosis: a study 
with scanning electron microscopy and energy dispersive X-ray analysis. Br J Ind Med. 1991; 
48:327–331. [PubMed: 2039745] 
Gulati and Redlich Page 12













51. Collard HR, Moore BB, Flaherty KR, et al. Acute exacerbations of idiopathic pulmonary fibrosis. 
Am J Respir Crit Care Med. 2007; 176:636–643. [PubMed: 17585107] 
52. George TJ, Arnaoutakis GJ, Shah AS. Lung transplant in idiopathic pulmonary fibrosis. Arch Surg. 
2011; 146:1204–1209. [PubMed: 22006881] 
53. King TE Jr, Bradford WZ, Castro-Bernardini S, et al. A phase 3 trial of pirfenidone in patients with 
idiopathic pulmonary fibrosis. N Engl J Med. 2014; 370:2083–2092. [PubMed: 24836312] In a 
phase 3 study of 555 IPF patients, pirfenidone treatment reduced disease progression as measured 
by pulmonary function testing decline, exercise tolerance and progression-free survival.
54. Richeldi L, du Bois RM, Raghu G, et al. Efficacy and safety of nintedanib in idiopathic pulmonary 
fibrosis. N Engl J Med. 2014; 370:2071–2082. [PubMed: 24836310] In phase 3 trials of 1066 IPF 
patients, nintedenib, a triple kinase inhibitor of multiple tyrosine kinases, slowed disease 
progression based on forced vital capacity decline. Diarrhea was a common side effect.
55. Raghu G, Anstrom KJ, King TE Jr, et al. Idiopathic Pulmonary Fibrosis Clinical Research 
Network. Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. N Engl J Med. 
2012; 366:1968–1977. [PubMed: 22607134] 
56. Yamamoto S. Histopathological features of pulmonary asbestosis with particular emphasis on the 
comparison with those of usual interstitial pneumonia. Osaka City Med J. 1997; 43:225–242. 
[PubMed: 9540344] 
Gulati and Redlich Page 13














• IPF may have known causes and association.
• Asbestosis, a diffuse interstitial lung disease, develops insidiously after years of 
chronic asbestos exposure and may appear indistinguishable from IPF.
• Several epidemiologic investigations worldwide of IPF have suggested a 
number of possible occupational and environmental causes such as exposure to 
cigarette smoke, wood dust, metal dust, sand/silica and agricultural exposures.
• The essential elements of the IPF and asbestosis diagnostic work-up include a 
high index of clinical suspicion and the HRCT. Histopathologic confirmation is 
not routinely required.
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FIGURE 1. Asbestosis high-resolution chest CT scan
(a) HRCT lung windows demonstrate lower lobe predominant disease with evidence of 
reticular markings and honeycombing. (b) Mediastinal windows reveal evidence of pleural 
thickening and calcfiications (Courtesy of Jonathan Killam, MD and Ami Rubinowitz, MD). 
CT, computed tomography.
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FIGURE 2. Histopathology of usual interstitial pneumonia
(a) Reveals a low-power UIP view showing temporal heterogeneity with areas of abnormal 
lung alternating with normal lung. (b) Reveals a fibroblast focus representing an area of 
active fibroblast proliferation typically seen in UIP patients (Courtesy of Robert Homer, 
MD, PhD). UIP, usual interstitial pneumonia.
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FIGURE 3. Asbestos body
Asbestos bodies seen on iron stained section represent asbestos fibers surrounded by a 
coating of iron and protein. Definitive identification of the enclosed fibers requires scanning 
electron microscopy and energy dispersive X-ray analysis (Courtesy Robert Homer, MD, 
PhD).
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